Additional file 3 of A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with asthma
Philippe Bareille
Susan Tomkins
Varsha Imber
Mohammed Tayob
Karen Dunn
Rashmi Mehta
Sanjeev Khindri
10.6084/m9.figshare.11805474.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_of_A_randomized_double-blind_placebo-controlled_parallel-group_study_of_once-daily_inhaled_fluticasone_furoate_on_the_hypothalamic_pituitary_adrenocortical_axis_of_children_with_asthma/11805474
Additional file 3: Table S1. Derived SC weighted mean (0–24 h) (SC and ITT population), geometric mean SC AUC0–24 (SC population), geometric mean 24-h UC excretion (UC population), and geometric mean 6-β hydroxycortisol excretion (UC population).
2020-02-05 04:48:55
Asthma
Pediatric
Fluticasone furoate (FF)
Safety, HPA axis
Serum cortisol